1. Chew SS, Kerr NM, Danesh-Meyer HV. Giant cell arteritis. J Clin Neurosci. 2009. 16:1263–1268.
2. Chang HK, Hur SH, Chung HR. A case of giant cell arteritis developed in polymyalgia rheumatica. J Korean Rheum Assoc. 2000. 7:72–76.
3. Seo JW, Hur J, Kim HO, Jeon DH, Baek JH, Kim JH, et al. A case of atypical giant cell arteritis presenting as Raynaud's phenomenon and diagnosed by random temporal artery biopsy. J Korean Rheum Assoc. 2010. 17:278–282.
4. Arnaud L, Haroche J, Malek Z, Archambaud F, Gambotti L, Grimon G, et al. Is (18)F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis? Arthritis Rheum. 2009. 60:1193–1200.
5. Breuer GS, Nesher G, Nesher R. Rate of discordant findings in bilateral temporal artery biopsy to diagnose giant cell arteritis. J Rheumatol. 2009. 36:794–796.
6. Czihal M, Tatò F, Förster S, Rademacher A, Schulze-Koops H, Hoffmann U. Fever of unknown origin as initial manifestation of large vessel giant cell arteritis: diagnosis by colour-coded sonography and 18-FDG-PET. Clin Exp Rheumatol. 2010. 28:549–552.
7. Direskeneli H, Aydin SZ, Merkel PA. Assessment of disease activity and progression in Takayasu's arteritis. Clin Exp Rheumatol. 2011. 29:1 Suppl 64. S86–S91.
8. Wang X, Hu ZP, Lu W, Tang XQ, Yang HP, Zeng LW, et al. Giant cell arteritis. Rheumatol Int. 2008. 29:1–7.
9. Cantini F, Niccoli L, Nannini C, Bertoni M, Salvarani C. Diagnosis and treatment of giant cell arteritis. Drugs Aging. 2008. 25:281–297.
10. Nesher G, Berkun Y, Mates M, Baras M, Rubinow A, Sonnenblick M. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum. 2004. 50:1332–1337.